unknown
Stage
About
Inhalon Biopharma Inc is a clinical-stage biotechnology company developing inhaled monoclonal antibody treatments for acute respiratory infections such as RSV, influenza, and SARS-CoV-2 to enable a simplified test-to-treat care model.
Explore Inhalon Biopharma Inc's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.